Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
56.4M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$250M
-
Value change
-
+$9.02M
-
Put/Call ratio
-
0.27
-
Number of buys
-
31
-
Number of sells
-
-47
-
Price
-
$4.44
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q3 2023
105 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.4M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11.6M shares), FMR LLC (5.98M shares), RTW INVESTMENTS, LP (5.82M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.72M shares), COWEN AND COMPANY, LLC (4.31M shares), VANGUARD GROUP INC (2.64M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.41M shares), TRV GP IV, LLC (2.34M shares), BlackRock Inc. (1.45M shares), and Jefferies Financial Group Inc. (1.43M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.